+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rosacea - Pipeline Review, H2 2019

  • ID: 4901313
  • Drug Pipelines
  • December 2019
  • Region: Global
  • 90 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Aiviva BioPharma Inc
  • AOBiome LLC
  • BioPharmX Inc
  • Cutanea Life Sciences Inc
  • ELORAC Inc
  • Hovione FarmaCiencia SA
  • MORE
Rosacea - Pipeline Review, H2 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Rosacea - Pipeline Review, H2 2019, provides an overview of the Rosacea (Dermatology) pipeline landscape.

Rosacea is a chronic and potentially life-disruptive disorder primarily of the facial skin, often characterized by flare-ups and remissions. Symptoms include frequent redness of the face, or flushing, small, red lines under the skin, a swollen nose and thick skin, usually on the forehead, chin, and cheeks. The predisposing factors include age and family history of rosacea. Treatment includes antibiotics and acne drugs.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Rosacea - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Rosacea (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Rosacea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Rosacea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 9, 4, 8 and 1 respectively.

Rosacea (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Rosacea (Dermatology).
  • The pipeline guide reviews pipeline therapeutics for Rosacea (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Rosacea (Dermatology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Rosacea (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Rosacea (Dermatology)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Rosacea (Dermatology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Rosacea (Dermatology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aiviva BioPharma Inc
  • AOBiome LLC
  • BioPharmX Inc
  • Cutanea Life Sciences Inc
  • ELORAC Inc
  • Hovione FarmaCiencia SA
  • MORE
Introduction
Report Coverage
Rosacea - Overview
Rosacea - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Rosacea - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Rosacea - Companies Involved in Therapeutics Development
Accuitis Pharmaceuticals Inc
Afecta Pharmaceuticals Inc
Aiviva BioPharma Inc
AlfaSigma SpA
AOBiome LLC
Biomimetix JV LLC
BioPharmX Inc
Botanix Pharmaceuticals Ltd
Cellix Bio Pvt Ltd
Cutanea Life Sciences Inc
Dermata Therapeutics LLC
ELORAC Inc
Emeriti Pharma AB
Foamix Pharmaceuticals Ltd
GlycoMira Therapeutics Inc
Hovione FarmaCiencia SA
Matrisys Bioscience Inc
PHI Therapeutics Inc
Sol-Gel Technologies Ltd
Sunny Pharmtech Inc
TWi Biotechnology Inc
Rosacea - Drug Profiles
Rosacea - Dormant Projects
Rosacea - Discontinued Products
Rosacea - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Rosacea, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Rosacea - Pipeline by Accuitis Pharmaceuticals Inc, H2 2019
Rosacea - Pipeline by Afecta Pharmaceuticals Inc, H2 2019
Rosacea - Pipeline by Aiviva BioPharma Inc, H2 2019
Rosacea - Dormant Projects, H2 2019
Rosacea - Dormant Projects, H2 2019 (Contd..1), H2 2019
Rosacea - Discontinued Products, H2 2019

List of Figures
Number of Products under Development for Rosacea, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Accuitis Pharmaceuticals Inc
  • Afecta Pharmaceuticals Inc
  • Aiviva BioPharma Inc
  • AlfaSigma SpA
  • AOBiome LLC
  • Biomimetix JV LLC
  • BioPharmX Inc
  • Botanix Pharmaceuticals Ltd
  • Cellix Bio Pvt Ltd
  • Cutanea Life Sciences Inc
  • Dermata Therapeutics LLC
  • ELORAC Inc
  • Emeriti Pharma AB
  • Foamix Pharmaceuticals Ltd
  • GlycoMira Therapeutics Inc
  • Hovione FarmaCiencia SA
  • Matrisys Bioscience Inc
  • PHI Therapeutics Inc
  • Sol-Gel Technologies Ltd
  • Sunny Pharmtech Inc
  • TWi Biotechnology Inc
Note: Product cover images may vary from those shown
Adroll
adroll